- IRAN: We Have Captured 17 CIA Spies
- Bipartisan Bill Encourages Marijuana Research
- China’s Knockoff Nasdaq Blasts Off With 140% One-Day Gain
- How Clean is Your Hamburger?
IRAN: We Have Captured 17 CIA Spies
Has Already Sentenced Several to Death
Iran says it arrested a secret ring of 17 CIA spies over the last year. And they’ve sentenced some of them to death. And they made a documentary about it. And you should check out our cool new documentary about arresting CIA spies, it’s out today.
(Editor’s note: Last week, I said Iran trying to pretend one of its drones wasn’t shot down by a U.S. tanker was the most bizarre chapter in this story. I lied. This is the most bizarre chapter. And it’s probably only going to get weirder from here on out. So buckle up.)
Iran intelligence says it arrested 17 CIA spies working in military and nuclear facilities and the private sector over the course of the 12 months leading up to March of this year. (I’m starting to think they just arrested a bunch of their own people.)
A top Iranian intelligence official told reporters that: “Sentences for these spies have been issued, some of whom are to be put to death as ‘corruptors on earth’ [a charge punishable by death under Islamic rules in Iran].”
President Trump, who will never pass up for a chance to make headlines with a tweet, hopped on Twitter to dispute the claims:
The official didn’t say how many of the alleged CIA spies had been sentenced to death. But he did say that they made a documentary about the whole thing and that they would be releasing it today, July 22. (There are easier ways to drum up publicity for your film than kickstarting a war, Iran.)
We’ll have more on this geopolitical headache as it develops. (Trust me, there’ll be more.)
Bipartisan Bill Encourages Marijuana Research
A bipartisan group of lawmakers has introduced a bill to congress (“Bill, this is Congress. Congress, this is Bill.”) that would eliminate several restrictions on marijuana research in the United States.
The bill would allow scientists to buy and study “research-grade” cannabis from private manufacturers. (Or as scientists in the private sector call it, “the kindest of buds.”)
Right now, weed scientists (or “apprentices of the Devil’s Lettuce” as they’re known in the scientific community) are only authorized to test marijuana grown in a federally-authorized facility at the University of Mississippi.
As you can imagine, government-approved mari-huana ain’t exactly high-quality stuff. In fact, according to the researchers, it’s barely weed at all, and closer chemically to hemp. (And you need the good, good weed to do science, say researchers.)
The bill would also establish a “less cumbersome registration process” for researchers by “reducing approval wait times, costly security measures, and additional, unnecessary layers of protocol review.”
We Stand United (But for Opposite Reasons)
In a twist worthy of a TV show that gets canceled because of allegations of sexual harassment against its star, the bill has support from not just both sides of the aisle, but both side of the legalization argument.
The bills six sponsors (a 3:3 Dem-Republican salad) include marijuana advocate Earl Blumenauer (D-OR) and vocal legalization critic Andy Harris (R-MD).
“At first glance, it may seem like a strange partnership—one of the most vocal critics of the ever-advancing tide of cannabis legalization and one of legalization’s most ardent advocates—co-sponsoring a cannabis bill together,” said Blumenauer and Harris, in a cute little op-ed they co-authored.
“Dig a bit deeper into the debate, however, and our odd couple makes a bit more sense. We may come from different sides of the issue, but we can agree on one thing—the federal government should not stand in the way of legitimate, scientific medical cannabis research.”
Basically, despite their positions, both politicians are saying the debate is kinda pointless without more scientific research. And the only way you’re going to get that is by loosening up those regulations.
“While we may disagree about the medical value of cannabis and the various state efforts to legalize cannabis,” said the entity comprised of Blumenauer and Harris. “It is beyond dispute that the barriers to cannabis research inhibit this nation’s ability to both thoroughly evaluate the benefits and risks associated with increased cannabis use and craft responsible policy governing such use.”
Canada’s “Pot Pension Payouts”
As pointed out by Representative Blumenauer: “[Forty-seven] states have legalized some form of cannabis.” It’s only a matter of time before we see legalization on a federal level.
That’ll be a blockbuster day for the U.S. stock market. But right now, thousands of savvy Americans are already cashing in on a Canadian government trusted “Pot Pension Payout” program.
“Pot Pension Payouts” are a new 100% legal way to collect income up to an average of $2,717 and even $6,112 per month by piggybacking off of Canadian pension funds.
And the best part is you don’t have to live, work, or directly invest in Canada or even leave your home in the U.S. to start collecting.
However, according to my research team, you must get in by July 25 for maximum income.
Click here now to get all the details about one of the greatest “hidden” marijuana opportunities of all time
China’s Knockoff Nasdaq Blasts Off With 140% One-Day Gain
China’s knockoff Nasdaq had a blistering opening day, minting a fresh batch of new Chinese tech billionaires. (They say every time a new stock market opens, a tech billionaire gets his manbun.)
However, analysts predict that this government-fueled high will come with a colossal propaganda-state hangover. (Sorry, I still need to get the drugs terminology out of my system from the last article.)
The Nasdaq-esque Star is part of an effort to bring Chinese tech companies home and give them access to the vast wealth of Chinese investors.
On average, the 25 stocks that debuted on Star today gained 140% by the time the market closed. Shares in Anji Microelectronics Technology shot up as much as 520% before trimming those gains to close at 400% up.
However, analysts say the surge was driven by unrealistic expectations among investors, fueled by state propaganda.
“This [surge] is crazy,” said Ronald Wan, chief executive of Partners Capital International in Hong Kong, according to CNN. “But it’s already overdone. I don’t think such gains can last long. It’s way too speculative.”
China is so desperate to make Star work and bring its major tech companies home, it’s loosening some of its notoriously strict market regulations (“Well, Mrs. China. I do believe you’re trying to seduce me”).
For the first time, companies that are not actually making any money will be allowed to list in China — emulating the U.S. IPO model. (Which has given rise to some of our most annoying billionaires.)
Star enjoyed some major hype on its first day of trading. But expect to see some major corrections in the coming days as investors come to their senses. (Like how everybody thought Jaden Smith was going to be the next big thing but it turned out that all that money and fame had just made him weird.)
In Other News
ONE LAST THING
The $280k Burger Could Shatter the Farming Industry
Last week, we reported that the plant-based meat industry would grow by 28% a year and reach $85 billion by 2030.
But there’s a new innovation that threatens to disrupt this growing market and upend the American farming industry in the process. (And you bet your bottom burger it’s weirder than any pea-protein burger could ever be.)
Clean meat is not made from plants. Its real meat “produced by the in-vitro cultivation of animal cells.” In essence, lab-grown meat or meat without the animal.
With this technique, you could grow a porterhouse steak in a lab… and there’d be no cow involved. Just the steak.
If folks could get on board with this frankenmeat (and it was affordable/didn’t cause folks to grow a second head), it would upend the American farm industry.
It’s not a new technology. But until now it’s been prohibitively expensive.
Netherlands-based food tech brand Mosa Meat first introduced the world to its lab-grown hamburger in 2013 for the low-low price of $280,000 per patty. (And that’s before you add lettuce and mayo.)
But, according to a Mosa Meat spokesperson that price has come way down in the years since:
“The burger was this expensive in 2013 because back then it was novel science and we were producing at very small scale. Once production is scaled up, we project the cost of producing a hamburger will be around €9 [$10].”
Mosa predicts that its cell-based meat could eventually become more affordable than the price of a traditional hamburger. They would of course. They want to keep their investors.
But there are dozens of companies working to words the same goal as Mosa. And many of them are aiming to hit commercial supermarkets by 2020 or 2021.
Clean meat may be frightening to some, but as we saw this year with Beyond Meat, there’s a market for animal-friendly food products. And we could be looking at a major disruption of one of America’s oldest industries in the next five to ten years.
We’re watching this one closely.
Closing Data for 7/19/19
S&P Index 500$2,976.79↓ 0.61%
- Chinese investment in the U.S. has fallen nearly 90% since President Trump took office in 2016.
- Equifax (EFX) to pay up to $700 million in data breach settlement, stemming from a 2017 data breach that exposed the personal data of nearly 150 million Americans.
- Avengers: Endgame beats Avatar as the highest-grossing movie of all time (not adjusting for inflation).
Editor, One Last Thing